Julia Jeck

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acinetobacter Baumannii

Top Venues

Cost effectiveness and resource allocation : C/E

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs, Anna Kron, Jennifer Franz, Oliver Andreas Cornely, Florian Kron
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre. Mycoses (2023)
Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs, Jennifer Franz, Christoph T Baltin, Anna Kron, Boris Böll, Matthias Kochanek, Oliver Andreas Cornely, Florian Kron
Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany. Healthcare (Basel, Switzerland) 10 (12) (2022)
Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs, Jennifer Franz, Christoph T Baltin, Anna Kron, Boris Böll, Matthias Kochanek, Oliver Andreas Cornely, Florian Kron
Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany. Healthcare (Basel, Switzerland) 10 (12) (2022)
Julia Jeck, Florian Jakobs, Anna Kron, Jennifer Franz, Oliver A Cornely, Florian Kron
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospital. Infection (2021)
Julia Jeck, Sebastian M Wingen-Heimann, Christian Thielscher, Anna Kron, Jennifer Bonn, Florian Jakobs, Santiago Grau, David A Enoch, Christianne Micallef, Oliver Andreas Cornely, Florian Kron
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazole. Mycoses 64 (10) (2021)